162 related articles for article (PubMed ID: 11954744)
1. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.
Ohno T; Yuge T; Kariyazono H; Igarashi H; Joh-o K; Kinugawa N; Kusuhara K; Hara T
Eur J Pediatr; 2002 Feb; 161(2):105-11. PubMed ID: 11954744
[TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.
Ohno T; Igarashi H; Inoue K; Akazawa K; Joho K; Hara T
Eur J Pediatr; 2000 Jun; 159(6):424-9. PubMed ID: 10867847
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
Maeno N; Takei S; Masuda K; Akaike H; Matsuo K; Kitajima I; Maruyama I; Miyata K
Pediatr Res; 1998 Oct; 44(4):596-9. PubMed ID: 9773852
[TBL] [Abstract][Full Text] [Related]
4. Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Heart Vessels; 2000; 15(3):105-11. PubMed ID: 11289497
[TBL] [Abstract][Full Text] [Related]
5. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions.
Hamamichi Y; Ichida F; Yu X; Hirono KI; Uese KI; Hashimoto I; Tsubata S; Yoshida T; Futatani T; Kanegane H; Miyawaki T
Pediatr Res; 2001 Jan; 49(1):74-80. PubMed ID: 11134495
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
Heeschen C; Dimmeler S; Hamm CW; Boersma E; Zeiher AM; Simoons ML;
Circulation; 2003 Feb; 107(4):524-30. PubMed ID: 12566361
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor in acute Kawasaki disease.
Terai M; Yasukawa K; Narumoto S; Tateno S; Oana S; Kohno Y
Am J Cardiol; 1999 Feb; 83(3):337-9. PubMed ID: 10072219
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.
Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kitano M; Kakishita E
Br J Haematol; 2002 Mar; 116(4):796-802. PubMed ID: 11886383
[TBL] [Abstract][Full Text] [Related]
9. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease.
Takeshita S; Kawamura Y; Takabayashi H; Yoshida N; Nonoyama S
Clin Exp Immunol; 2005 Mar; 139(3):575-9. PubMed ID: 15730405
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
11. Obesity is associated with increased levels of circulating hepatocyte growth factor.
Rehman J; Considine RV; Bovenkerk JE; Li J; Slavens CA; Jones RM; March KL
J Am Coll Cardiol; 2003 Apr; 41(8):1408-13. PubMed ID: 12706940
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of vascular leakage in acute Kawasaki disease.
Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y
Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221
[TBL] [Abstract][Full Text] [Related]
13. Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.
Ebata R; Abe J; Yasukawa K; Hamada H; Higashi K; Suwazono Y; Saito H; Terai M; Kohno Y
Circ J; 2011; 75(6):1455-62. PubMed ID: 21483160
[TBL] [Abstract][Full Text] [Related]
14. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
16. Increased angiogenic growth factor in cyanotic congenital heart disease.
Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
[TBL] [Abstract][Full Text] [Related]
17. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Cardiology; 2000; 93(3):168-74. PubMed ID: 10965088
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease.
Srivastava M; Zurakowski D; Cheifetz P; Leichtner A; Bousvaros A
J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):548-53. PubMed ID: 11740227
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.
Nishimura S; Zaitsu M; Hara M; Yokota G; Watanabe M; Ueda Y; Imayoshi M; Ishii E; Tasaki H; Hamasaki Y
J Pediatr; 2003 Sep; 143(3):357-62. PubMed ID: 14517520
[TBL] [Abstract][Full Text] [Related]
20. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
